Proteome Systems Ltd. Release: US And Australian Biotechs Collaborate To Develop New Semen-Based Non-Invasive Prostate Cancer Test; Prostate Cancer Associated Biomarker Identified By Proteome Systems Just Days Prior To Prostate Cancer Awareness Month

BOSTON--(BUSINESS WIRE)--Sept. 6, 2006--Just days prior to Prostate Cancer Awareness Month (September 2006) a leading biotech team developing a semen-based prostate cancer test -- designed to improve on the accuracy of the prostate-specific antigen (PSA) test -- has identified a prostate cancer biomarker associated with Human Carcinoma-Antigen (HCA). When present along with HCA, the biomarker will form the basis of a new prostate cancer diagnostic test being developed by Proteome Systems.